use alternative contraceptive methods during treatment initiation and for 4 weeks after each dose escalation [11] Concomitant medications: Avoid coadministration with other GLP-1 receptor agonists for weight management Patients should be advised to seek medical attention for: Severe, persistent abdominal pain that may radiate to the back (potential pancreatitis) Signs of thyroid tumors including neck mass, dysphagia, dyspnea, or persistent hoarseness Symptoms of acute gallbladder disease (right upper quadrant pain, fever, jaundice) Severe gastrointestinal symptoms leading to dehydration Changes in vision or signs of hypoglycemia Signs of hypersensitivity reactions including rash, itching, or difficulty breathing Clinicians should conduct a thorough medical history before initiating tirzepatide, including assessment for personal or family history of medullary thyroid carcinoma or MEN 2, history of pancreatitis, severe gastrointestinal disease, and diabetic retinopathy

Semaglutides patents havent expired yet
Other symptoms: Note down any pelvic pain, severe cramping, dizziness, or unusual fatigue
Your healthcare provider may recommend gradual dose escalation over the first month to minimize adjustment effects
Figura 1
Your appointment will cover your weight-loss goals in addition to the state of your general health, your past health history, and more